A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Virological Methods

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jviromet.2009.02.027PMID 19442845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.

  2009cited by this paper
• Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.

  2009cited by this paper
• Dynamics of lamivudine‐resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy

  2008cited by this paper
• Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.

  2008cited by this paper
• The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

  2008cited by this paper
• Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure

  2008cited by this paper
• Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S Antigen

  2008cited by this paper
• Technique for the Early Detection of Drug-Resistant HBV DNA during Antiviral Therapy

  2008cited by this paper
• Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B

  2007cited by this paper
• High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus.

  2007cited by this paper
• Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.

  2007cited by this paper
• Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management

  2007cited by this paper
• Detection of hepatitis B virus genotypes using oligonucleotide chip among hepatitis B virus carriers in Eastern China.

  2007cited by this paper
• Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

  2006cited by this paper
• Mutations affecting the replication capacity of the hepatitis B virus

  2006cited by this paper
• Detection of YMDD mutants using universal template real-time PCR.

  2006cited by this paper
• A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.

  2006cited by this paper
• Quantification of the relative levels of wild‐type and lamivudine‐resistant mutant virus in serum of HBV‐infected patients using microarray

  2005cited by this paper
• Evaluation of the MagNA Pure LC used with the TRUGENE HBV Genotyping Kit.

  2005cited by this paper
• Advances in Molecular Diagnosis of HBV Infection and Drug Resistance

  2005cited by this paper
• Evaluation of Methods for Monitoring Drug Resistance in Chronic Hepatitis B Patients during Lamivudine Therapy Based on Mass Spectrometry and Reverse Hybridization

  2005cited by this paper
• Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine

  2005cited by this paper
• Detection of mutations in the hepatitis B virus polymerase gene.

  2003cited by this paper
• The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus.

  2002cited by this paper
• Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay

  2002cited by this paper
• High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

  2000cited by this paper
• Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e Antigen–negative patients receiving lamivudine therapy

  2000cited by this paper
• Efficacy of long‐term lamivudine monotherapy in patients with hepatitis B e antigen–negative chronic hepatitis B

  2000cited by this paper
• Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.

  1999cited by this paper

• Immune Escape and Drug Resistance Mutations in Patients with Hepatitis B Virus Infection: Clinical and Epidemiological Implications

  2025cites this paper
• Mechanism Research of QingReJieDu Formula for Treating Hepatitis B Virus Based on Network Pharmacology.

  2024cites this paper
• Increased interleukin-32, interleukin-1, and interferon-γ levels in serum from hepatitis B patients and in HBV-stimulated peripheral blood mononuclear cells from healthy volunteers.

  2019cites this paper
• Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana

  2018cites this paper
• Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment

  2017cites this paper
• Integrating nested PCR with high-throughput sequencing to characterize mutations of HBV genome in low viral load samples

  2017cites this paper
• Oligonucleotide-based biosensors for in vitro diagnostics and environmental hazard detection

  2016cites this paper
• Analytical and clinical evaluation of the Abbott RealTime hepatitis B sequencing assay.

  2016cites this paper
• Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments

  2015influential citation
• Occult Hepatitis B Infection in Patients With Cryptogenic Liver Cirrhosis in Southwest of Iran

  2015cites this paper
• Prevalence of YMDD Variants Leading to Lamivudine Resistance among Chronic HBV Patients in Gaza Strip-Palestine

  2015cites this paper
• A case-control study on occult hepatitis B infection in chronic hemodialysis patients from south-west of Iran.

  2015cites this paper
• BPA Bisphenol A cDNA Complementary DNA CEA Carcinoembryonic antigen CSF Cerebrospinal fluid EDC Endocrine-disrupting compound FRET Fluorescence resonance energy transfer G4 G-quadruplex HBV Hepatitis B virus HRCA Hyperbranched rolling circle amplification HRP Horseradish peroxidase LSPR Localized su

  2015influential citation
• Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan.

  2015cites this paper
• In different proveniences of Iran the prevalence of HBV infection A Case-Control Study on Occult Hepatitis B Infection in Chronic Hemodialysis Patients from South-West of Iran

  2015cites this paper
• Prior Exposure to Lamivudine Increases Entecavir Resistance Risk in Chronic Hepatitis B Patients without Detectable Lamivudine Resistance

  2014cites this paper
• Unsafe Injection Practices: A Potential Weapon for the Outbreak of Blood Borne Viruses in the Community

  2013cites this paper
• Sensitive and specific HBV genomic DNA detection using RCA-based QCM biosensor

  2013cites this paper
• The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment

  2013cites this paper
• Hospital Cluster of HBV Infection: Molecular Evidence of Patient-to-Patient Transmission through Lancing Device

  2012cites this paper
• Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B.

  2011cites this paper
• Rapid identification of YVDD mutants of hepatitis B virus using smart amplification process with competition probe.

  2011cites this paper